Vaxart Inc Analysis

Vaxart Stock Analysis Notes

The company has Price to Book (P/B) ratio of 1.5. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Vaxart Inc recorded a loss per share of 0.26. The entity last dividend was issued on the 9th of November 2012. The firm had 1:11 split on the 14th of February 2018. Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company is headquartered in South San Francisco, California. Vaxart operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 110 people. For more information please call Cezar MBA at 650 550 3500 or visit https://vaxart.com.

Vaxart Inc Investment Alerts

Vaxart Inc Upcoming and Recent Events

Vaxart Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 73.03 M.

Vaxart Profitablity

The company has Profit Margin (PM) of (1.23) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.72) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.72.

Technical Drivers

As of the 20th of July, Vaxart has the Semi Deviation of 6.34, risk adjusted performance of 0.0519, and Coefficient Of Variation of 2173.54. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vaxart Inc, as well as the relationship between them.

Vaxart Inc Price Movement Analysis

Vaxart Inc Insider Trading Activities

Vaxart Outstanding Bonds

Vaxart Predictive Daily Indicators

Vaxart Forecast Models

Vaxart's time-series forecasting models are one of many Vaxart's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vaxart's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Vaxart prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Vaxart shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Vaxart. By using and applying Vaxart Stock analysis, traders can create a robust methodology for identifying Vaxart entry and exit points for their positions.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxart Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

If you are still planning to invest in Vaxart Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaxart's history and understand the potential risks before investing.